AKY15-HK-301_NEPA Study

计划入组 55 人 · 首次发布于 2017 年 12 月 29 日

To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers

计划入组 56 人 · 首次发布于 2018 年 8 月 29 日

Essential Pro Study ( rEPIC04E-HK )

计划入组 100 人 · 首次发布于 2024 年 10 月 8 日

HK-1

HK-241

HK-01

HK inno.N Corporation

South Korea

Innovent Biologics (HK) Limited

Hong Kong, China

CHEERAIN HK LIMITED

Hong Kong, China

HK Innoen's K-CAB Receives Brazilian GMP Certification, Advances Global Market Expansion

HK inno.N Partners with NEXTGEN to Advance IPF Drug NXC680 into Phase 1 Clinical Trials

HK inno.N Advances Obesity Drug IN-B00009 to Phase 3 Trial in South Korea